Upsurge in Generic Medicines to drive the Pharmaceutical Glass Packaging Market

Generic medicines are being used at a broader scale. This factor, along with the fact that glass does act as a hindrance to the atmospheric gases like oxygen and carbon dioxide drives the pharmaceutical glass packaging market. As such, risk of drugs getting contaminated gets mitigated. Also, the drugs don’t turn out to be susceptible to degradation like oxidation and hydrolysis. Additionally, volatile ingredients can’t escape through glass packaging. Thus, retention of drug stability in a nutshell helps in driving the demand for pharmaceutical glass packaging.

Biotech drugs and cost-sensitivity are being asked for, which has, in turn, resulted in stern regulations pertaining to delivery of drugs. Coming to syringes, Gerresheimer AG has its metal-free 1 ml Gx RTF long Luer Lock syringe wherein the pin used for shaping the cone is made from an exclusive ceramic material in place of the traditional tungsten.

To get exclusive insights on the Pharmaceutical Glass Packaging Market@ https://www.persistencemarketresearch.com/market-research/pharmaceutical-glass-packaging-market.asp

The way the Market Disperses

By type of packaging, the pharmaceutical glass packaging market spans syringes, bottles, ampoules and vials, and cartridges. By route of administration, it’s injectable, oral, nasal, and topical. By type of material, it’s type I, type II, and type III. Out of these, syringes and bottles hold the largest market share. Oral route of administration is preferred as many people are sceptical of getting injected.

The future is bound to witness an increasing demand for vials as they have better analytical performance coupled with better sustainability. Type 1 borosilicate glass is the material used for making these vials. It does impart the chemical resistance needed. The ampoules are manufactured complying with the DIN ISO EN 9187-1/2 standard in straight-stem, funnel-type, and sealed designs.

Analysis: Region-wise

North America holds the largest market share. It holds more than 30% of the overall market share. This could be credited to extensive spending on pharmaceuticals. Europe stands second herein. The Asia-Pacific is expected to grow at the fastest rate in the forecast period due to the governments promoting low-cost generic drugs, thereby reducing the healthcare costs on the whole. This factor is bound to revitalize the pharmaceutical glass packaging market in this region. Players like Schott AG and Corning enter into partnership with various small-scale units over here, which, in turn, helps in expansion at the regional level.

By Competition

The key players in the pharmaceutical glass packaging market include Schott AG, Gerresheimer AG, Becton, Dickinson and Company, Owens-Illinois, Inc., Ardagh Group S.A., Nipro Corporation, West Pharmaceutical Services, Inc., Stevenato Group (Ompi), O.Berk Company, LLC, DWK Life Sciences GmbH, Beatson Clark Ltd., Piramal Glass Limited, Acme Vial and Glass Company, LLC, Amposan S.A., SGD Pharma, Hindustan National Glass Co., Ltd., Bormioli Pharma Srl, and others. Coming to developments, SGD S.A. upgraded its plants in Spain and China to dole out products in greater numbers. The company, in August 2018, did invest close to US$ 7.8 Mn for rebuilding furnace, thereby boosting the overall production by close to 11%.